Lancer Orthodontics, Inc.

FRC's fair value estimate for Lancer Orthodontics, Inc., and the rating behind it. LANZ last traded at $0.03, 4.0× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Lancer Orthodontics, Inc.. Starting points for Lancer Orthodontics, Inc.: P/E 4.0, EPS $0.01, beta 0.50 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Lancer Orthodontics, Inc.. Lancer Orthodontics, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Lancer Orthodontics, Inc.. Trailing twelve-month EPS for Lancer Orthodontics, Inc. stands at $0.01. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Lancer Orthodontics, Inc.. Lancer Orthodontics, Inc. has reported as a listed company since 1986. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Lancer Orthodontics, Inc. valued side by side against its closest peers. Lancer Orthodontics, Inc. is measured against Medical - Specialties peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Lancer Orthodontics, Inc., and how their positions are changing. At a $74,488 market value, institutional positions materially move Lancer Orthodontics, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Lancer Orthodontics, Inc. executives and directors. Shares of Lancer Orthodontics, Inc. have traded between $0.0015 and $0.03 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Lancer Orthodontics, Inc.. Lancer Orthodontics, Inc. is a $74,488 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Lancer Orthodontics, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Lancer Orthodontics, Inc.. Coverage tracks Lancer Orthodontics, Inc. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.